The Food & Drug Administration warned AngioDynamics Inc. (NSDQ:ANGO) for some allegedly over-zealous marketing of its NanoKnife system.
The FDA accused the Latham, N.Y.-based company of making statements on its website promoting the use of the device beyond its approved indications.